LIVAZEBE
Live / Registered — Registered (as of 24 Dec 2024)
What this means for you
Registered since 24 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79399425
- Registration number
- 7617325
- Mark type
- Stylized text
- Filed
- 31 May 2024
- Published for opposition
- 05 Nov 2024
- Registered
- 24 Dec 2024
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, pharmaceutical preparations for treatment of fatty liver and steatohepatitis, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the treatment of digestive system disease, pharmaceutical preparations for the treatment of primary biliary cirrhosis, pharmaceutical preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, pharmaceutical preparations for the treatment of liver disease, pharmaceutical preparations for the treatment of metabolic disease, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, analgesics; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; veterinary preparations, namely, veterinary preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, veterinary preparations for treatment of fatty liver and steatohepatitis, veterinary preparations for the treatment of cardiovascular disorders and metabolic disorders, veterinary preparations for the treatment of digestive system disease, veterinary preparations for the treatment of primary biliary cirrhosis, veterinary preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, veterinary preparations for the treatment of liver disease, veterinary preparations for the treatment of metabolic disease, veterinary preparations for the prevention and treatment of disorders of the metabolic system, analgesics; veterinary pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; veterinary pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; sanitary preparations for medical use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain.
Owner
- KOWA COMPANY, LTD., JP
- KOWA COMPANY, LTD., JP
- KOWA COMPANY, LTD., JP
Prosecution history
- 18 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 03 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 03 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 23 Jan 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 24 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 05 Nov 2024 — PUBLISHED FOR OPPOSITION
- 16 Oct 2024 — NOTICE OF PUBLICATION
- 24 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Sept 2024 — ASSIGNED TO EXAMINER
- 12 Jul 2024 — APPLICATION FILING RECEIPT MAILED
- 12 Jul 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Jul 2024 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 05 Jul 2024 — SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB